RGNX – REGENXBIO Inc.
Float Short %
10.76
Margin Of Safety %
Put/Call OI Ratio
0.47
EPS Next Q Diff
-0.19
EPS Last/This Y
1.33
EPS This/Next Y
1.08
Price
8.13
Target Price
29.83
Analyst Recom
1.42
Performance Q
-27.64
Upside
-1,600.6%
Beta
1.1
Ticker: RGNX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | RGNX | 13.79 | 0.42 | 3.26 | 5794 |
| 2026-01-26 | RGNX | 13.87 | 0.69 | 0.36 | 7260 |
| 2026-01-27 | RGNX | 13.43 | 0.59 | 0.47 | 8836 |
| 2026-01-28 | RGNX | 11.01 | 0.57 | 1.47 | 9877 |
| 2026-01-29 | RGNX | 11.6 | 0.77 | 0.64 | 11410 |
| 2026-01-30 | RGNX | 11.16 | 0.73 | 4.79 | 12195 |
| 2026-02-02 | RGNX | 10.76 | 0.87 | 6.06 | 13378 |
| 2026-02-03 | RGNX | 10.87 | 0.92 | 0.70 | 13978 |
| 2026-02-04 | RGNX | 10.77 | 0.92 | 0.73 | 14331 |
| 2026-02-05 | RGNX | 10.28 | 0.88 | 0.48 | 15725 |
| 2026-02-06 | RGNX | 10.32 | 0.83 | 0.85 | 16467 |
| 2026-02-09 | RGNX | 10.3 | 0.80 | 6.52 | 17726 |
| 2026-02-10 | RGNX | 8.84 | 0.89 | 1.74 | 18554 |
| 2026-02-11 | RGNX | 8.48 | 0.61 | 2.05 | 19196 |
| 2026-02-12 | RGNX | 8.34 | 0.55 | 2.42 | 19143 |
| 2026-02-13 | RGNX | 7.98 | 0.54 | 0.34 | 19098 |
| 2026-02-17 | RGNX | 8.03 | 0.50 | 0.38 | 19276 |
| 2026-02-18 | RGNX | 7.89 | 0.49 | 0.11 | 18995 |
| 2026-02-19 | RGNX | 8.41 | 0.47 | 3.61 | 19428 |
| 2026-02-20 | RGNX | 8.13 | 0.47 | 0.14 | 19542 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | RGNX | 13.79 | 22.6 | 222.9 | -3.26 |
| 2026-01-26 | RGNX | 13.85 | 22.6 | 243.0 | -3.26 |
| 2026-01-27 | RGNX | 13.42 | 22.6 | 237.7 | -3.26 |
| 2026-01-28 | RGNX | 11.03 | 22.6 | 215.6 | -3.26 |
| 2026-01-29 | RGNX | 11.61 | 22.6 | 251.3 | -3.26 |
| 2026-01-30 | RGNX | 11.15 | 22.6 | 236.1 | -3.26 |
| 2026-02-02 | RGNX | 10.76 | 22.6 | 236.6 | -3.26 |
| 2026-02-03 | RGNX | 10.85 | 22.6 | 243.3 | -3.26 |
| 2026-02-04 | RGNX | 10.77 | 22.6 | - | -3.26 |
| 2026-02-05 | RGNX | 10.29 | 22.6 | - | -3.26 |
| 2026-02-06 | RGNX | 10.32 | 22.6 | - | -3.26 |
| 2026-02-09 | RGNX | 10.30 | 22.6 | - | -3.26 |
| 2026-02-10 | RGNX | 8.84 | 22.6 | - | -3.26 |
| 2026-02-11 | RGNX | 8.49 | 22.6 | - | -3.26 |
| 2026-02-12 | RGNX | 8.35 | 22.6 | - | -3.26 |
| 2026-02-13 | RGNX | 7.99 | 16.9 | - | -3.26 |
| 2026-02-17 | RGNX | 8.03 | 16.9 | - | -3.26 |
| 2026-02-18 | RGNX | 7.89 | 16.9 | - | -3.26 |
| 2026-02-19 | RGNX | 8.41 | 16.9 | - | -3.26 |
| 2026-02-20 | RGNX | 8.13 | 16.9 | - | -3.26 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | RGNX | -0.71 | -0.65 | 10.90 |
| 2026-01-26 | RGNX | -0.71 | -0.04 | 10.90 |
| 2026-01-27 | RGNX | -0.71 | -0.04 | 10.90 |
| 2026-01-28 | RGNX | -0.71 | -0.04 | 11.24 |
| 2026-01-29 | RGNX | -0.71 | -0.04 | 11.24 |
| 2026-01-30 | RGNX | -0.71 | -0.04 | 11.24 |
| 2026-02-02 | RGNX | -0.71 | -0.08 | 11.24 |
| 2026-02-03 | RGNX | -0.71 | -0.08 | 11.24 |
| 2026-02-04 | RGNX | -0.71 | -0.08 | 11.24 |
| 2026-02-05 | RGNX | -0.71 | -0.08 | 11.24 |
| 2026-02-06 | RGNX | -0.71 | -0.08 | 11.24 |
| 2026-02-09 | RGNX | -0.71 | 0.07 | 11.24 |
| 2026-02-10 | RGNX | -0.71 | 0.07 | 11.24 |
| 2026-02-11 | RGNX | -0.71 | 0.07 | 10.70 |
| 2026-02-12 | RGNX | -0.71 | 0.07 | 10.70 |
| 2026-02-13 | RGNX | -0.71 | 0.07 | 10.70 |
| 2026-02-17 | RGNX | -0.71 | 3.00 | 10.76 |
| 2026-02-18 | RGNX | -0.68 | 3.00 | 10.76 |
| 2026-02-19 | RGNX | -0.68 | 3.00 | 10.76 |
| 2026-02-20 | RGNX | -0.68 | 3.00 | 10.76 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.2
Avg. EPS Est. Current Quarter
-0.8
Avg. EPS Est. Next Quarter
-1.39
Insider Transactions
-0.68
Institutional Transactions
3
Beta
1.1
Average Sales Estimate Current Quarter
61
Average Sales Estimate Next Quarter
68
Fair Value
Quality Score
40
Growth Score
45
Sentiment Score
49
Actual DrawDown %
82.5
Max Drawdown 5-Year %
-88.4
Target Price
29.83
P/E
Forward P/E
PEG
P/S
2.55
P/B
2.55
P/Free Cash Flow
EPS
-3.49
Average EPS Est. Cur. Y
-3.26
EPS Next Y. (Est.)
-2.18
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-110.29
Relative Volume
1.13
Return on Equity vs Sector %
-139.2
Return on Equity vs Industry %
-121.7
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.06
EBIT Estimation
REGENXBIO Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 353
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase III clinical trial for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I, RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2, and RGX-381 for the treatment of the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
stock quote shares RGNX – REGENXBIO Inc. Stock Price stock today
news today RGNX – REGENXBIO Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RGNX – REGENXBIO Inc. yahoo finance google finance
stock history RGNX – REGENXBIO Inc. invest stock market
stock prices RGNX premarket after hours
ticker RGNX fair value insiders trading